DV Trading LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 904.6% during the first quarter, HoldingsChannel.com reports. The firm owned 14,074 shares of the exchange traded fund’s stock after acquiring an additional 12,673 shares during the quarter. DV Trading LLC’s holdings in SPDR S&P Biotech ETF were worth $1,798,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the company. Axiom Investment Management LLC bought a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at about $26,000. Financial Life Planners bought a new position in shares of SPDR S&P Biotech ETF in the first quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $30,000. Finally, SHP Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $31,000.
SPDR S&P Biotech ETF Stock Down 2.9%
Shares of XBI opened at $147.01 on Friday. SPDR S&P Biotech ETF has a twelve month low of $84.39 and a twelve month high of $165.71. The company has a market capitalization of $9.70 billion, a P/E ratio of 11.47 and a beta of 0.82. The firm has a 50 day moving average of $146.16 and a 200 day moving average of $134.34.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
